Globally, Glaucoma is on rise. According to the Glaucoma research Foundation, Glaucoma is the leading cause of irreversible blindness globally. Nearly 10% of the glaucoma patients who receive proper treatment still experience a loss of vision. Around 64.3 million people were estimated to be having glaucoma globally in 2013. Furthermore, according to the American Academy of Ophthalmology, the current prevalence is high in Africa, and Latin America. Patients who fail to respond to medications, undergo trabeculectomy surgery. However, few patients do not get completely relieved from glaucoma even after trabeculectomy surgery. Therefore, novel treatment options are required to be introduced for providing relief to such patients. Reducing intra-ocular pressure is the most important long term medical need of refractory glaucoma patients.
Refractory Glaucoma Treatment Options
The global refractory glaucoma treatment market can be characterized based on the treatment options and devices available in the market.
Ahmed Glaucoma Valve from New World Medical Inc., is a good treatment option available since 1993 for refractory glaucoma. This device also has applications in primary open angle glaucoma unresponsive to medication, neovascular glaucoma, and congenital or infantile glaucoma. Various studies have reflected the positive outcomes of using Ahmed Glaucoma Valve in refractory glaucoma both in pediatrics and adults. Therefore, this device is in very high demand and usage globally.
Alternate option like CyPass Micro-Stent from Transcend Medical showed impressive results in patients with primary open-angle glaucoma. CyPass is a micro-invasive surgery which according to the FDA guidelines needs to be performed in combination with cataract surgery. This is restricting the wider acceptance among patients due to increased cost.
Clinical trials of Xen System showed positive results with 44% reduction in eye pressure and 65% reduction in IOP medications in one year period. The Xen gel stent form Allergan reduces IOP with a permanent implant that becomes flexible, allowing doctors to use IOP reduction therapies event after the Xen implantation. Allergan received U.S. FDA approval for Xen Gel stent in November 2016. The company plans to launch the Xen Gel stent in the U.S. market, for refractory glaucoma treatment, in early 2017. The Xen system has already received CE mark and has distributed more than 10,500 stents globally. Moreover, the new surgical system is also licensed for use in Canada, Switzerland, and Turkey.
Iridex Corporation, a global provider of innovative laser systems, device and consumables in ophthalmology announced at the European Glaucoma Society held in June 2016 about the positive results of its MicroPulse P3 (MP3) device. The device powered with MicroPulse laser technology showed long term benefits for patients with refractory glaucoma. Few detailed studies with successful outcomes could lead global acceptance of this technology in future.
Glaucoma drainage devices are frequently used in refractory glaucoma to reduce the intra-ocular pressure (IOC). These devices are available in either with IOP regulating valves or without it. Ahmed glaucoma valve (AGV) is the most commonly used valve-based drainage device while Molteno, Baerveldt, Shocket, and Eagle Vision implants are the non-valved drainage devices available in the market.
Future Market Dynamics
According to the American Academy of Ophthalmology, the global prevalence of glaucoma is estimated to rise to 76 million in 2020 and 111.8 million in 2040. Rapidly aging population will be one of the important factors for the increasing prevalence rate. There would be a disproportionate rise in the prevalence in people residing in Asia and Africa. Slower adoption rate and high cost of the surgery is limiting the market growth of refractory glaucoma treatment devices in emerging nations where cataract surgery is the largely performed eye surgery. With new devices and technology being introduced, there could be a strong wave of growth experienced in the North America and European markets.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.